Zhongzhi Pharmaceutical Holdings (HKSE:03737) Total Inventories : HK$371 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Total Inventories?

Zhongzhi Pharmaceutical Holdings's total inventories for the quarter that ended in Jun. 2024 was HK$371 Mil. Zhongzhi Pharmaceutical Holdings's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was HK$366 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zhongzhi Pharmaceutical Holdings's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was HK$-0.38.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zhongzhi Pharmaceutical Holdings's Days Inventory for the six months ended in Jun. 2024 was 134.42.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zhongzhi Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zhongzhi Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.31.

Zhongzhi Pharmaceutical Holdings Total Inventories Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Total Inventories Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

221.48

292.95

328.23

360.59

360.97

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Inventories	Get a 7-Day Free Trial															300.82	360.59	330.62	360.97	370.73

Zhongzhi Pharmaceutical Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Zhongzhi Pharmaceutical Holdings's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

	Net-Net Working Capital Per Share (Q: Jun. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(175.378	+	0.75 * 317.055	+	0.5 * 370.734	-	915.088
-	0	-	5.272)	/	845.300
=	-0.38

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zhongzhi Pharmaceutical Holdings's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2024 )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
	=	365.85	/	496.696	*	365 / 2
	=	134.42

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zhongzhi Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2024 )	/	Average Total Inventories (Q: Jun. 2024 )
	=	496.696	/	365.85
	=	1.36

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zhongzhi Pharmaceutical Holdings's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	365.85	/	1171.738
	=	0.31

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Zhongzhi Pharmaceutical Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines